Literature DB >> 8585423

Cloning and complete coding sequence of a novel human cathepsin expressed in giant cells of osteoclastomas.

Y P Li1, M Alexander, A L Wucherpfennig, P Yelick, W Chen, P Stashenko.   

Abstract

A gene encoding a possible novel human cathepsin, a cysteine proteinase that is distinct from previously characterized enzymes, has been identified by differential screening of a human osteoclastoma cDNA library. This molecule, termed cathepsin X, appears to represent the human homolog of the osteoclast-expressed rabbit cathepsin OC-2. Cathepsin X (GenBank accession number U20280) is 93.9% identical to OC-2 at the amino acid level, and is 92% identical at the nucleotide level within the coding region. Cathepsin X is 52.2 and 46.9% identical to cathepsins S and L, respectively, and is therefore clearly distinct from these enzymes. Cathepsin X mRNA was localized to multinucleated giant cells within the osteoclastoma tumor by in situ hybridization. These data strongly support the hypothesis that cathepsin X represents a novel cysteine proteinase which is expressed at high levels in osteoclasts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8585423     DOI: 10.1002/jbmr.5650100809

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  26 in total

1.  Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis.

Authors:  W S Hou; D Brömme; Y Zhao; E Mehler; C Dushey; H Weinstein; C S Miranda; C Fraga; F Greig; J Carey; D L Rimoin; R J Desnick; B D Gelb
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

2.  The silencing of cathepsin K used in gene therapy for periodontal disease reveals the role of cathepsin K in chronic infection and inflammation.

Authors:  W Chen; B Gao; L Hao; G Zhu; J Jules; M J MacDougall; J Wang; X Han; X Zhou; Y-P Li
Journal:  J Periodontal Res       Date:  2016-01-11       Impact factor: 4.419

3.  Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation.

Authors:  Shuying Yang; Wei Chen; Philip Stashenko; Yi-Ping Li
Journal:  J Cell Sci       Date:  2007-10-01       Impact factor: 5.285

Review 4.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

5.  Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence.

Authors:  Wei Chen; Shuying Yang; Yoke Abe; Ming Li; Yucheng Wang; Jianzhong Shao; En Li; Yi-Ping Li
Journal:  Hum Mol Genet       Date:  2007-01-08       Impact factor: 6.150

6.  RGS12 is essential for RANKL-evoked signaling for terminal differentiation of osteoclasts in vitro.

Authors:  Shuying Yang; Yi-Ping Li
Journal:  J Bone Miner Res       Date:  2007-01       Impact factor: 6.741

7.  Monocyte-Specific Knockout of C/ebpα Results in Osteopetrosis Phenotype, Blocks Bone Loss in Ovariectomized Mice, and Reveals an Important Function of C/ebpα in Osteoclast Differentiation and Function.

Authors:  Wei Chen; Guochun Zhu; Joel Jules; Diep Nguyen; Yi-Ping Li
Journal:  J Bone Miner Res       Date:  2018-01-26       Impact factor: 6.741

8.  C1 Silencing Attenuates Inflammation and Alveolar Bone Resorption in Endodontic Disease.

Authors:  Yuhui Wang; Wei Chen; Liang Hao; Abigail McVicar; Jinjin Wu; Ning Gao; Yuehua Liu; Yi-Ping Li
Journal:  J Endod       Date:  2019-05-16       Impact factor: 4.171

9.  C/EBPα regulates osteoclast lineage commitment.

Authors:  Wei Chen; Guochun Zhu; Liang Hao; Mengrui Wu; Hongliang Ci; Yi-Ping Li
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-11       Impact factor: 11.205

10.  IL-1alpha stimulates cathepsin K expression in osteoclasts via the tyrosine kinase-NF-kappaB pathway.

Authors:  S Kamolmatyakul; W Chen; S Yang; Y Abe; R Moroi; A M Ashique; Y-P Li
Journal:  J Dent Res       Date:  2004-10       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.